We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Andrx, Glaxo In New Row Over Wellbutrin

Law360 (December 20, 2005, 12:00 AM EST) -- Extending the drawn-out legal row over generic Wellbutrin, a subsidiary of Andrx Pharmaceuticals LLC has sued British rival GlaxoSmithKline PLC, alleging the company’s current formula for the antidepressant infringes Andrx’s patent.

The complaint, filed in the U.S. District Court for the Southern District of Florida, also names Glaxo subsidiary SmithKline Beecham Corp. It points to the defendant’s extended-release, 150 mg doses as the source of infringement.

Andrx applied for the patent in the case in May 2003, and it was issued in June 2005. It covers...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.